CTRI/2019/07/019981
Not yet recruiting
未知
Rheumatological manifestations and drug utilization study in Diabetes Mellitus.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
- Sponsor
- All India Institute of Medical Sciences
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •all patients diagnosed with diabetes mellitus ( Type 1 and type 2\)
Exclusion Criteria
- •All individuals diagnosed as Gestational Diabetes, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Effects of therapeutic medication for rheumatoid arthritis on cachexia in patients with rheumatoid arthritis.rheumatoid arthritisJPRN-UMIN000017026Tokushima University100
Not yet recruiting
Not Applicable
Musculoskeletal and rheumatological manifestations in COVID-19CTRI/2021/10/037694Maulana Azad Medical College
Completed
Not Applicable
Combination anti-rheumatic drugs in early rheumatoid arthritisOrthopaedics, rheumatologyMusculoskeletal DiseasesRheumatoid arthritisISRCTN32484878Medical Research Council (MRC) (UK)468
Active, not recruiting
Phase 1
Patients with rheumatoid arthritis and synovitis treated with ultrasound guided intraarticular or intramuscular glucocorticoid injection - A randomised, double-blind, controlled study (Panguian)Treatment of synovitis among rheumatoid arthritis patientsMedDRA version: 21.0Level: PTClassification code 10042868Term: SynovitisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2017-003425-15-DKVidencenter for Reumatologi og Rygsygdomme, Rigshospitalet100
Recruiting
Not Applicable
rheumatoid arthritis: observation of biologics treatmentM05M06Seropositive rheumatoid arthritisOther rheumatoid arthritisDRKS00031523Deutsches Rheuma-Forschungszentrum Berlin30,000